Table 2. Patient characteristics.
| PDAC (SS) | PDAC (LS) | |
|---|---|---|
| Sex (female/male) | 3/6 | 7/3 |
| Age [median (range), year] | 64 (48–74) | 71 (43–77) |
| Diabetes mellitus | 5 | 4 |
| Tumor location pancreas head |
9 | 10 |
| Tumor diameter (cm) | 2.5 (1–6) | 3 (2–7) |
| Lymph node metastasis | 4 | 7 |
| Staging | ||
| IIA | 5 | 3 |
| IIB | 4 | 7 |
| R1 resection | 4 | 3 |
| Surgery | 9 | 10 |
| Adjuvant chemotherapy | 5 | 9 |
| Gemcitabine | 3 | 5 |
| 5-FU | 1 | 1 |
| Capecitabine | 0 | 2 |
| Gemcitabine, 5-FU | 1 | 0 |
| Gemcitabine, Capecitabine | 0 | 1 |
| Radiotherapy | 1 | 0 |
| Survival (mean (SD), month) | 7.3 (1.9–11.5) | 59.1 (47.0–120.9) |
Abbreviations: PDAC: Pancreatic ductal adenocarcinoma; SS: short survival; LS: long survival.